Jefferies Group’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Jefferies Group’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-7,043	Closed	-$1.22M	–	3686
2015 Q1	$1.22M	Sell	7,043 -35,570	-83%	-$5.22M	0.01%	958
2014 Q4	$4.9M	Buy	+42,613	New	+$5.16M	0.03%	434
2014 Q3	–	Sell	-341	Closed	-$49.4K	–	2696
2014 Q2	$42K	Sell	341 -10,571	-97%	-$1.17M	﹤0.01%	1941
2014 Q1	$1.13M	Buy	+10,912	New	+$1.12M	0.01%	862
2013 Q4	–	Sell	-10,317	Closed	-$690K	–	2423
2013 Q3	$690K	Buy	10,317 +8,268	+404%	+$570K	0.01%	1078
2013 Q2	$136K	Buy	+2,049	New	+$117K	﹤0.01%	1607

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Jefferies Group's SLXP Position: Q2 2015 in Review

Jefferies Group sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 7,043 shares — an estimated $1.22M sold.

Jefferies Group first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $4.9M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Jefferies Group reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Jefferies Group sold 7,043 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $1.22M.
Jefferies Group first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 6 quarters.
Jefferies Group's SALIX PHARMACEUTICALS LTD DEL position peaked at $4.9M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Jefferies Group's 13F filing for Q2 2015, filed 18 Aug 2015.